Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 Patients: A Systematic Review of Current Evidence
- Authors: Ghavimehr E.1,2, Zand A.1,2, SeyedAlinaghi S.A.2, Karimi A.3, Zaferani Arani H.1, Mirzapour P.2, Pashaei Z.2, Mehraeen E.2,4, Dadras O.2,5
-
Affiliations:
- School of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
- Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- Department of Health Information Management, Arabdil University of Medical Sciences, Khalkhal, Iran
- Department of Global Public Health and Primary Care, Graduate School of Medicine, Bergen University, Bergen, Norway
- Issue: Vol 22, No 1 (2024)
- Section: Medicine
- URL: https://ruspoj.com/2211-3525/article/view/642299
- DOI: https://doi.org/10.2174/2211352521666230714160740
- ID: 642299
Cite item